ROMA (Risk of Ovarian Malignancy Algorithm) is an FDA cleared algorithm presented in mobile application. The application is intended for educational purposes only by clinicians, who are trained in using ROMA. This application was developed by AbiTech, Inc. on the behalf of the University of Rochester Wilmont Cancer Institute. The ROMA algorithm is trademarked by Roche, and was developed by Dr. Richard Moore, MD, at the University of Rochester.
UR Medicine’s Wilmot Cancer Institute (WCI) features an 84-bed cancer center with 11 outpatient locations throughout the Rochester and Finger Lakes region. Wilmot, a component of Strong Memorial Hospital, offers patients and their families comprehensive services including one of upstate New York’s largest blood and marrow transplant programs and the Rochester area’s only ACOS-accredited breast cancer center. Wilmot is home to the region’s first survivorship clinic and offers clinical trials of new therapies and options that may not be available anywhere else upstate. In addition, Wilmot includes a team of scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care.
UR Medicine’s Wilmot Cancer Institute (WCI) features an 84-bed cancer center with 11 outpatient locations throughout the Rochester and Finger Lakes region. Wilmot, a component of Strong Memorial Hospital, offers patients and their families comprehensive services including one of upstate New York’s largest blood and marrow transplant programs and the Rochester area’s only ACOS-accredited breast cancer center. Wilmot is home to the region’s first survivorship clinic and offers clinical trials of new therapies and options that may not be available anywhere else upstate. In addition, Wilmot includes a team of scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care.
Show More
